Abstracts

MOLECULAR DETERMINANTS OF HIV HYPERMUTATION

The human genome encodes seven APOBEC3 (A3) enzymes, at least four of which (A3D, A3F, A3G, and A3H) can induce G-to-A mutations in HIV-1 genomes. These enzymes leave two distinct hypermutation signatures: GG-to-AG and GA-to-AA. The former signature is dominant in viral sequences hypermutated in vitro by A3G, whereas the latter is prevalent in sequences…

INCREASED INFLAMMATION AND MONOCYTE ACTIVATION IN HIV-EXPOSED UNINFECTED INFANTS

HIV infection is accompanied by high levels of inflammation that predict increased mortality in adults. HIV-exposed uninfected (HEU) infants also have increased infectious morbidity and mortality, but little is known about their levels of inflammation and immune activation. In this study, we assessed how inflammatory and monocyte activation markers correlated between mothers and HEUs at…

INNATE IMMUNE ACTIVATION AMONG HIV-1 EXPOSED UNINFECTED INFANTS FROM BOTSWANA

HIV-exposed uninfected (HEU) infants continue to experience increased morbidity/mortality from infectious causes compared with infants born to HIV-uninfected women. To explore possible immune etiologies, we conducted an immune profiles analysis, comparing profiles from a Botswana-based cohort of HEU to HIV-unexposed (HU) infants. Multiparametric flow cytometry was used to quantify proportions and phenotypic characteristics of innate…

MICROBIAL TRANSLOCATION, IMMUNE ACTIVATION, AND GUT DYSBIOSIS IN HIV-EXPOSED INFANTS

The MITABS study (Microbial Translocation[MT], Immune Activation[IA], and Altered Bowel Flora Study[ABS]) is the first prospective, longitudinal study designed to simultaneously assess MT, IA, and alterations in the gut microbiome with clinical events in young (enrolled at < 6 months) HIV perinatally infected (HEI); and perinatally exposed, uninfected(HEU) infants in the Dominican Republic (DR) before…

QUANTIFYING INDIRECT BENEFITS OF PrEP: MODELING ANALYSIS OF ORAL PrEP IN ZIMBABWE

HIV incidence remains high among adolescent girls and young women (AGYW) in Zimbabwe. Tenofovir-based oral pre-exposure prophylaxis (PrEP) can prevent individual infection, but population level impact and disaggregation of the direct (primary) and indirect (secondary/onward) preventive effects remain unexplored for this population. We assessed potential population-level benefits of oral PrEP use among female sex workers…